- Home
- SEVN vs NRXP Comparison
SEVN vs NRXP Comparison
Compare SEVN & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEVN | NRXP |
|---|---|---|
| Founded | 1986 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.9M | 151.1M |
| IPO Year | 2008 | 2017 |
Fundamental Metrics
Financial Performance| Metric | SEVN | NRXP |
|---|---|---|
| Price | $6.55 | $2.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $9.00 | ★ $38.50 |
| AVG Volume (30 Days) | 198.9K | ★ 699.8K |
| Earning Date | 10-27-2026 | 11-16-2026 |
| Dividend Yield | ★ 16.94% | N/A |
| EPS Growth | N/A | ★ 69.70 |
| EPS | ★ 0.51 | N/A |
| Revenue | ★ $29,383,000.00 | $1,225,000.00 |
| Revenue This Year | $15.96 | $357.94 |
| Revenue Next Year | $15.62 | $1,507.30 |
| P/E Ratio | $12.93 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.98 | $1.65 |
| 52 Week High | $9.81 | $5.06 |
Technical Indicators
Market Signals| Indicator | SEVN | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | 29.11 |
| Support Level | $5.98 | $1.68 |
| Resistance Level | $8.84 | $2.49 |
| Average True Range (ATR) | 0.21 | 0.22 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 57.48 | 20.95 |
Price Performance
Historical ComparisonAbout SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.